ArticleJournal of clinical medicine2024

A Systemic Immune Inflammation Index and PD-L1 (SP142) Expression as a Potential Combined Biomarker of the Clinical Benefit of Chemo-Immunotherapy in Extensive-Stage Small-Cell Lung Cancer.

Jong-Min Baek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.